Michael Kelly
Director/Miembro de la Junta en PRIME MEDICINE, INC. .
Fortuna: 1 M $ al 30/04/2024
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Robert Bradway | M | 61 | 18 años | |
Lynn Tetrault | F | 61 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | 9 años |
Bradley Campbell | M | 48 | 18 años | |
Michael Kuta | M | 49 | 10 años | |
David Aldous | M | 67 | 11 años | |
Douglas Van Oort | M | 68 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | 15 años |
Stephen Kanovsky | M | 61 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | 7 años |
Catherine Stehman-Breen | M | 61 |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | 17 años |
Keith Gottesdiener | M | 70 | 4 años | |
Rachel Stahler | F | 48 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | 4 años |
Alison Hannah | M | 63 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | 9 años |
Graziano Seghezzi | M | 55 |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | 11 años |
Sander J. van Deventer | M | 69 |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | 10 años |
Oren Gilad | M | 56 | 2 años | |
Mike Raab Raab | M | 59 | 20 años | |
Daniel D. Pinschewer | M | 49 |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | 13 años |
Raymond R. Hipp | M | 81 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | 13 años |
Kevin Johnson | M | 69 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | 14 años |
Timothy Reilly | M | 50 | 2 años | |
Matthew Busch | M | 50 | 20 años | |
Elizabeth Floegel | F | 48 | 1 años | |
Brett Seger | M | 40 | 2 años | |
Jeffrey D. Marrazzo | M | 46 |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | 2 años |
Alicia Olivo | F | 40 | 2 años | |
Paul-Henri Lambert | M | 85 |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | 9 años |
Ellen Rosenberg | F | 61 | 8 años | |
David Reese | M | 61 | 19 años | |
Steven Brodie | M | 63 | 9 años | |
Michael Grissinger | M | 68 | 2 años | |
Neil Gunn | M | 63 | 1 años | |
Eiry Roberts | M | 60 | 3 años | |
Esteban Santos | M | 56 | 17 años | |
Jill Weimer | M | - | 5 años | |
David Kaufman | M | 51 | 5 años | |
Marc Duey | M | 68 | 2 años | |
Vic Myer | M | - |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | 4 años |
Carman Alenson | F | 58 | 3 años | |
Thomas Cahill | M | 37 |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | 3 años |
Mary Coelho | F | 62 | 1 años | |
Melody Harris | F | 58 | 2 años | |
Charles Holley | M | 67 | 7 años | |
Gregory D. Aunan, | - | - | - | |
Anthony Zook | M | 63 | 1 años | |
Burke Whitman | M | 68 | 5 años | |
Lynn Bleil | F | 60 | 6 años | |
Margaret McGlynn | F | 64 | 15 años | |
Rifat Pamukcu | M | 66 | 2 años | |
Lori Johnston | F | 59 | 8 años | |
Chris Smith | M | 61 | 2 años | |
Glenn Sblendorio | M | 68 | 18 años | |
Ruth Dreessen | F | 68 | 4 años | |
Jonathan Graham | M | 63 | 9 años | |
Craig Wheeler | M | 63 | 8 años | |
David Perez | M | 63 | 2 años | |
Geoff High | M | - | - | |
James O'Leary | M | 61 | 1 años | |
Robert Shovlin | M | 53 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | 10 años |
Ouma Sananikone | F | 66 | 1 años | |
Tyler Jacks | M | 63 | 12 años | |
George Golumbeski | M | 67 |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | 2 años |
Clifton Rose | M | 73 | 8 años | |
Roman Necina | M | 56 | 5 años | |
Greg Garland | M | 66 | 11 años | |
Michelle Shepston | F | 49 | 8 años | |
Jeffrey Sherman | M | 58 | 2 años | |
Ellen Kullman | F | 68 | 8 años | |
Robert Eckert | M | 69 | 21 años | |
Haichen Yang | F | - | 3 años | |
Sébastien Martel | M | - | 3 años | |
Mitchell Goldman | M | - | 4 años | |
Shashikant Kulkarni | M | 57 | 2 años | |
Forrest Holmes Blocker | M | - | - | |
David Clark | M | 49 | 6 años | |
Diana Moore | F | - | 9 años | |
Simon Harford | M | 63 | 1 años | |
Mohammed Asmal | M | - | - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Steven Jones | M | 59 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | 18 años |
Daphne Quimi | F | 58 | 18 años | |
John Crowley | M | 57 | 22 años | |
Mark Mallon | M | 61 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | 1 años |
Kevin Longe | M | 65 | 11 años | |
Bill Bonello | M | 59 | 5 años | |
Kathryn McKenzie | F | 39 | 6 años | |
Paul Eisenberg | M | - | 14 años | |
Madhavan Balachandran | M | 73 | 20 años | |
Yvon Pierre Cariou | M | 78 | 21 años | |
George Cardoza | M | 62 | 13 años | |
Marc M. P. de Garidel | M | 66 | 15 años | |
David W. Beier | M | 75 | 10 años | |
Dennis Fenton | M | 72 | 27 años | |
James Tobin | M | 79 | 5 años | |
Kevin Sharer | M | 76 | 20 años | |
Richard Graff | M | 77 | 17 años | |
Pamela Wapnick | F | 58 | 9 años | |
William Ashton | M | 73 | 16 años | |
James Daly | M | 62 | 9 años | |
Robert Cohen | M | 75 | 13 años | |
Preston Klassen | M | 55 | 7 años | |
Raymond C. Jordan | M | 70 | 7 años | |
Katia Schlienger | M | 62 | 2 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 100 | 100.00% |
Austria | 4 | 4.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Michael Kelly
- Red Personal